LB
LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
$42.47 +0.59% (+$0.25)
1M -11.91%
Market Cap $1.22B
P/E Ratio -
Div. Yield -
ROE 25.91%
Piotroski F-Score Weak
2/9Valuation
56 /100
Fair P/B 3.66x
EV/EBITDA N/A
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 25.91%
ROA 23.69%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 15.08x
Debt/Equity 0.02x
Net debt/EBITDA N/A
Stability
21 /100
Unstable EPS volatility 567.68%
Profitable years 0
Beta 0.42x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na LBRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Heather D. Turner
Employees
49
Headquarters
New York
Nadcházející události
05 LIS
Earnings
Upcoming earnings report